[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate
C68H97N7O15 — CID 159873739
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate
[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate (PubChem CID 159873739) has the molecular formula C68H97N7O15 and a molecular weight of 1252.56 g/mol. Its IUPAC name is [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate.
Molecular Properties
| Compound Name | [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate |
|---|---|
| PubChem CID | 159873739 |
| Molecular Formula | C68H97N7O15 |
| Molecular Weight | 1252.56 g/mol |
| Exact Mass | 1251.70 |
| IUPAC Name | [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate |
| SMILES | CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)CCc3cnc(N4CCN(c5ncc(C(C)=O)cn5)CC4)nc3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C |
| InChI | InChI=1S/C68H97N7O15/c1-41-17-13-12-14-18-42(2)56(85-9)35-52-23-20-47(7)68(84,90-52)63(81)64(82)75-26-16-15-19-53(75)65(83)89-57(36-54(77)43(3)32-46(6)61(80)62(87-11)60(79)45(5)31-41)44(4)33-49-21-24-55(58(34-49)86-10)88-59(78)25-22-50-37-69-66(70-38-50)73-27-29-74(30-28-73)67-71-39-51(40-72-67)48(8)76/h12-14,17-18,32,37-41,43-45,47,49,52-53,55-58,61-62,80,84H,15-16,19-31,33-36H2,1-11H3/b14-12+,17-13-,42-18+,46-32+/t41-,43-,44-,45-,47-,49+,52+,53+,55-,56+,57+,58-,61-,62+,68-/m1/s1 |
| InChIKey | RJPCGOZRMPLBIY-UVJPEEKVSA-N |
| XLogP | 7.47 |
| TPSA | 276.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 90 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1252.56 |
| LogP ≤ 5 | 7.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159873739 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.